FDA: Puberty blockers linked to thousands of reactions and deaths
Drugs that are being used as a puberty blocker in gender-confused youth have been linked to tens of thousands of serious reactions and thousands of deaths, as well as other serious medical issues, according to More...
Becton Dickinson receives FDA clearance to market the BD MAX™ StaphSR Assay
Press Release BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced yesterday it has received FDA clearance to market the BD MAX™ StaphSR More...
BD Diagnostics, BD ProbeTec™ Trichomonas vaginalis Qx Amplified DNA Assay gets FDA clearance
Global medical technology company, BD Diagnostics, a segment of BD (Becton, Dickinson and Company) announced Tuesday the U.S. Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas More...
Meridian Bioscience, Inc. announces receiving FDA clearance for new molecular test for Group A Streptococcus
Cincinnati, Ohio company, Meridian Bioscience, Inc announced this week that it received clearance from the Food and Drug Administration (FDA) to market a new molecular diagnostic test for Group A Streptococcus. Note More...
